Cheshire, United Kingdom

Mark Andrew Graham



Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Macclesfield, GB (2011)
  • Cheshire, GB (2018 - 2019)

Company Filing History:


Years Active: 2011-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mark Andrew Graham: Innovator in Chemical Compounds

Introduction

Mark Andrew Graham is a notable inventor based in Cheshire, GB. He has made significant contributions to the field of chemical compounds, particularly in the development of pharmaceutical compositions for cancer treatment. With a total of three patents to his name, Graham's work is recognized for its potential impact on medical science.

Latest Patents

Graham's latest patents focus on chemical compounds that are crucial in the fight against cancer. The present disclosures concern compounds of Formula (I) or pharmaceutically-acceptable salts thereof, wherein R, R, and R have specific meanings defined in the description. These patents also detail processes for the preparation of these compounds, as well as pharmaceutical compositions containing them and their use in cancer treatment.

Career Highlights

Mark Andrew Graham is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to innovative solutions in healthcare, particularly in oncology.

Collaborations

Graham has collaborated with notable colleagues, including Clifford David Jones and Richard Andrew Ward. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical innovations.

Conclusion

Mark Andrew Graham's contributions to the field of chemical compounds and his dedication to cancer treatment exemplify the spirit of innovation in the pharmaceutical industry. His work continues to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…